Inotiv (NOTV)
(Delayed Data from NSDQ)
$1.48 USD
-0.05 (-3.27%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $1.48 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
Inotiv, Inc. (NOTV) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$4.67 | $10.00 | $2.00 | 205.23% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for Inotiv, Inc. comes to $4.67. The forecasts range from a low of $2.00 to a high of $10.00. The average price target represents an increase of 205.23% from the last closing price of $1.53.
Analyst Price Targets (3 )
Broker Rating
Inotiv, Inc. currently has an average brokerage recommendation (ABR) of 2.33 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by three brokerage firms. The current ABR compares to an ABR of 2.33 a month ago based on three recommendations.
Of the three recommendations deriving the current ABR, one is Strong Buy, representing 33.33% of all recommendations. A month ago, Strong Buy represented 33.33%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.33 | 2.33 | 2.33 | 2.33 | 2.33 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/16/2024 | Lake Street Capital Markets | Frank Takkinen | Hold | Hold |
5/16/2024 | Craig-Hallum | Matthew G Hewitt | Strong Buy | Strong Buy |
5/14/2024 | Not Identified | Not Identified | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.33 |
ABR (Last week) | 2.33 |
# of Recs in ABR | 3 |
Average Target Price | $4.67 |
LT Growth Rate | NA |
Industry | Medical - Drugs |
Industry Rank by ABR | 87 of 253 |
Current Quarter EPS Est: | 0.00 |
NOTV FAQs
Inotiv, Inc. (NOTV) currently has an average brokerage recommendation (ABR) of 2.33 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 3 brokerage firms.
The average price target for Inotiv, Inc. (NOTV) is $4.67. The current on short-term price targets is based on 1 reports.
The forecasts for Inotiv, Inc. (NOTV) range from a low of $2 to a high of $10. The average price target represents a increase of $205.23 from the last closing price of $1.53.
The current UPSIDE for Inotiv, Inc. (NOTV) is 205.23%
Based on short-term price targets offered by three analysts, the average price target for Inotiv, Inc. comes to $4.67. The forecasts range from a low of $2.00 to a high of $10.00. The average price target represents an increase of 205.23% from the last closing price of $1.53.